To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Homelessness: Coronavirus
Tuesday 27th February 2024

Asked by: Mike Amesbury (Labour - Weaver Vale)

Question to the Department for Levelling Up, Housing & Communities:

To ask the Secretary of State for Levelling Up, Housing and Communities, what data his Department holds on the number and proportion of individuals housed under the Everyone In initiative who continued to be provided with accommodation after covid-19 restrictions were lifted.

Answered by Felicity Buchan - Parliamentary Under Secretary of State (Department for Levelling Up, Housing and Communities)

Rough sleeping data collections are available here: Homelessness statistics.


Written Question
Vaccine Damage Payment Scheme: Coronavirus
Wednesday 21st February 2024

Asked by: Alexander Stafford (Conservative - Rother Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what proportion of (a) compensation and (b) successful applications of awards given out by the vaccine damage payment scheme related to a covid-19 vaccinations since the addition of the covid-19 vaccines to the vaccine damage payment scheme.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

Between COVID-19 being added to the Vaccine Damage Payment Scheme (VDPS) on 31 December 2020 and 5 February 2024, 163 claims have received an award that relates to COVID-19. This constitutes 98% of awarded VDPS claims in this period, with four claims receiving an award that relates to other diseases.

It is important to note that the VDPS is not a compensation scheme. £19,560,000 has been awarded for claims relating to COVID-19, including pending payments. This constitutes 98% of VDPS awards in this period, with £480,000 having been paid to awarded claims relating to other diseases.


Written Question
Domestic Abuse: Weather
Monday 19th February 2024

Asked by: Liz Twist (Labour - Blaydon)

Question to the Home Office:

To ask the Secretary of State for the Home Department, what assessment he has made of the impact of extreme weather on the risk of intimate partner violence.

Answered by Chris Philp - Minister of State (Home Office)

The Home Office has not made any formal assessment on the impact of extreme weather on the risk of intimate partner violence.

The prevalence of domestic abuse has remained relatively stable over recent years, but there was a decline seen between the year ending March 2020, a year largely unaffected by the coronavirus (COVID-19) pandemic, and the most recent figure for the year ending March 2023.

The government are taking important steps to tackle intimate partner violence, including implementation of the Tackling VAWG Strategy, Tackling Domestic Abuse Plan and the Domestic Abuse Act 2021.


Written Question
Medical Equipment: Coronavirus
Monday 19th February 2024

Asked by: Baroness Wolf of Dulwich (Crossbench - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Lord Markham on 24 January (HL1768), how many of each of the categories of equipment contained in that answer (1) are being offered or have been offered for sale in the period up to 31 March, (2) have been destroyed, (3) are scheduled for destruction, and (4) have been donated, or will be donated, to medical charities for use overseas, including but not confined to Ukraine.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The COVID Strategic ICU Reserve was set up in April 2020, in response to shortages in key respiratory equipment and in anticipation of increased demand during the pandemic. Over the last two years, the National Health Service has not needed to access the reserve to manage increases in the numbers of respiratory patients. With lack of demand from the NHS, and increasing costs associated with storing and maintaining ageing equipment, the decision was taken to close the reserve by March 2024.

Information on the money raised from the auction of equipment is not currently available. The following table shows the planned disposal routes for equipment within the COVID Strategic Intensive Care Unit Reserve from 1 December 2023 to 31 March 2024:

Holdings at December 2023

Offered or offering for sale

Have been destroyed

Scheduled for destruction

Donated to medical charities for use overseas

Enteral feed pumps

1140

1025

10

0

0

Humidifiers

4714

1456

0

3258

0

Mechanical ventilator - Anaesthetic

53

17

0

36

0

Mechanical ventilator - Emergency

5093

1140

3159

792

0

Mechanical ventilator - ICU

3083

3075

0

0

0

Mechanical ventilator - Transport

949

148

0

789

0

Non-invasive Ventilator (NIV) bilevel positive airway pressure (BiPaP)

3339

3085

0

252

0

NIV continuous positive airway pressure (CPAP)

6682

0

702

5980

0

NIV high flow nasal oxygen (HFNO)

187

155

0

0

0

Oxygen concentrators

2874

2861

0

13

0

Oxygen regulators

1564

1461

0

0

0

Patient monitors

2439

2353

0

0

0

Suction pumps

307

289

0

0

0

Syringe drivers

21319

8000

9318

3976

0

Volumetric pumps

1588

1563

0

0

0

Notes:

  1. The table does not include equipment that has been deployed to the NHS across the United Kingdom since December 2023, and so the sum of the disposal columns will not equal the December 2023 holdings. Information reflects plans as of 5 February 2024.
  2. Until the final closure of the reserve in March 2024, we will continue to respond to requests from the NHS and overseas meaning these plans are subject to change.

Written Question
Medical Equipment: Coronavirus
Monday 19th February 2024

Asked by: Baroness Wolf of Dulwich (Crossbench - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Lord Markham on 24 January (HL1768), how much money has been raised to date from the auction of equipment listed in that answer.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The COVID Strategic ICU Reserve was set up in April 2020, in response to shortages in key respiratory equipment and in anticipation of increased demand during the pandemic. Over the last two years, the National Health Service has not needed to access the reserve to manage increases in the numbers of respiratory patients. With lack of demand from the NHS, and increasing costs associated with storing and maintaining ageing equipment, the decision was taken to close the reserve by March 2024.

Information on the money raised from the auction of equipment is not currently available. The following table shows the planned disposal routes for equipment within the COVID Strategic Intensive Care Unit Reserve from 1 December 2023 to 31 March 2024:

Holdings at December 2023

Offered or offering for sale

Have been destroyed

Scheduled for destruction

Donated to medical charities for use overseas

Enteral feed pumps

1140

1025

10

0

0

Humidifiers

4714

1456

0

3258

0

Mechanical ventilator - Anaesthetic

53

17

0

36

0

Mechanical ventilator - Emergency

5093

1140

3159

792

0

Mechanical ventilator - ICU

3083

3075

0

0

0

Mechanical ventilator - Transport

949

148

0

789

0

Non-invasive Ventilator (NIV) bilevel positive airway pressure (BiPaP)

3339

3085

0

252

0

NIV continuous positive airway pressure (CPAP)

6682

0

702

5980

0

NIV high flow nasal oxygen (HFNO)

187

155

0

0

0

Oxygen concentrators

2874

2861

0

13

0

Oxygen regulators

1564

1461

0

0

0

Patient monitors

2439

2353

0

0

0

Suction pumps

307

289

0

0

0

Syringe drivers

21319

8000

9318

3976

0

Volumetric pumps

1588

1563

0

0

0

Notes:

  1. The table does not include equipment that has been deployed to the NHS across the United Kingdom since December 2023, and so the sum of the disposal columns will not equal the December 2023 holdings. Information reflects plans as of 5 February 2024.
  2. Until the final closure of the reserve in March 2024, we will continue to respond to requests from the NHS and overseas meaning these plans are subject to change.

Written Question
Coronavirus: Vaccination
Thursday 15th February 2024

Asked by: Lord Strathcarron (Conservative - Excepted Hereditary)

Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the answer by Lord Evans of Rainow on 11 January (HL Deb col 98), what assessment they have made of whether it is appropriate to describe COVID-19 vaccinations as “very safe” given that the Medicines and Healthcare products Regulatory Agency's Blue Guide, says that "advertising which states or implies that a product is 'safe' is unacceptable"; and whether they intend to publish the evidence base that supports the claim that the COVID-19 vaccinations are “very safe.”

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

All vaccines used in the United Kingdom must be authorised by the UK’s independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA). Each COVID-19 vaccine is only authorised once it has met robust standards of effectiveness, safety, and quality. As with all vaccines and medicines, the safety of COVID-19 vaccines is continuously monitored, and the advice from the MHRA remains that the benefits of vaccination in preventing COVID-19 and serious complications associated with COVID-19 outweigh any currently known side effects in the majority of patients. Information on the characteristics of each vaccine is published by the MHRA on the GOV.UK website. The MHRA’s Blue Guide relates to the advertising and promotion of medicinal products, and in general, debates in Parliament about vaccination are considered to be outside its scope.


Written Question
Education: Coronavirus
Wednesday 14th February 2024

Asked by: Lord Hunt of Kings Heath (Labour - Life peer)

Question to the Department for Education:

To ask His Majesty's Government what plans they have to provide COVID-19 catch-up learning for most disadvantaged pupils following the cessation of the National Tutoring Programme in August.

Answered by Baroness Barran - Parliamentary Under-Secretary (Department for Education)

The department acted swiftly in helping all children to recover from the impact of the pandemic and made available almost £5 billion for its ambitious multi-year programmes to support education recovery. These programmes were principally targeted at disadvantaged pupils, supporting the narrowing of the disadvantage gap to pre-pandemic levels as quickly as possible. Crucially, they were also designed to have a legacy beyond the multi-year period of exceptional and additional support.

Over £1 billion has been invested in tutoring over four years through the National Tutoring Programme (NTP). This has seen nearly 5 million tutoring courses commence since the programme started in November 2020, including over 2 million in each of the last two academic years. In the current academic year, 346,000 courses have started up to 5 October 2023.

The department anticipates that tutoring will continue to be a staple offer from schools, with schools using core budgets and pupil premium funding to provide targeted support for those children who will benefit.

Raising attainment for pupils is at the heart of this government’s agenda. The department knows that disadvantaged children have been disproportionately impacted by the pandemic and are committed to narrowing the attainment gap.

The department is continuing to support pupils’ needs by investing an extra £2 billion into core schools funding both this year and next year, over and above what it had already announced at the 2021 Spending Review. The department has also announced an additional £525 million this year to support schools with the teachers’ pay award, with a further £900 million in 2024/25. This means that by next year, school funding will be more than £59.6 billion, which is the highest ever level in real terms per pupil.

Schools receive the pupil premium to enable them to provide extra support to improve disadvantaged pupils’ academic and personal achievements. Pupil premium funding will rise to over £2.9 billion in 2024/25, which is an increase of £80 million from 2023/24. This represents a 10% increase in per pupil rates from 2021/22 to 2024/25.

Additionally, the department is investing in 55 Education Investment Areas, where outcomes in literacy and numeracy are the poorest, including £86 million in trust capacity funding to help strong trusts to expand into areas most in need of improvement.

Furthermore, students in 16-19 education during the 2024/25 academic year will continue to receive the additional 40 learning hours that the department is funding to help them catch up on the vital teaching and learning they need to progress. It is estimated that the additional hours will support the recovery of approximately one month of lost learning per academic year.


Written Question
Coronavirus: Vaccination
Wednesday 14th February 2024

Asked by: Lord Framlingham (Conservative - Life peer)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to investigate any possible link between COVID-19 vaccinations and increasing numbers of premature deaths from heart and circulatory conditions since 2020.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

There is no evidence linking excess deaths to the COVID-19 vaccine. Analysis from the Office for National Statistics, published on 25 August 2023, shows that people who died between 1 April 2021 and 31 May 2023 and who had a COVID-19 vaccine, had a lower mortality rate than those who had not been vaccinated.

Each COVID-19 vaccine is only authorised once it has met robust standards of effectiveness, safety and quality set by the Medicines and Healthcare Products Regulatory Agency (MHRA). No medicine or vaccine is completely risk-free, but the MHRA continually monitors the safety of the vaccines through a comprehensive vaccine surveillance strategy. This monitoring strategy is proactive and based on a wide range of information sources, with a dedicated team of scientists continually reviewing information to look for safety issues or any unexpected, rare events. Any information indicating a possible new safety concern is thoroughly evaluated, including through a review by the independent expert working group for COVID-19. Updated advice for healthcare professionals and patients is issued where appropriate.


Written Question
Hospitality Industry: Government Assistance
Tuesday 13th February 2024

Asked by: Marquess of Lothian (Conservative - Life peer)

Question to the HM Treasury:

To ask His Majesty's Government what steps they are taking to assist the hospitality industry in the UK, following both the coronavirus pandemic and cost of living crisis; and what consideration they have given to reducing VAT to 10 per cent for the hospitality industry.

Answered by Baroness Vere of Norbiton - Parliamentary Secretary (HM Treasury)

Since the start of the pandemic, over £37 billion has been provided to the tourism, leisure and hospitality sectors in the form of grants, loans and tax breaks.

The Government announced a package of business rates support at Autumn Statement 2022 which means businesses in the retail, hospitality and leisure sectors, including pubs, will receive a tax cut worth over £2 billion in 2023-24. The UK also has a higher VAT registration threshold than any EU Member State and the second highest in the OECD, which keeps most businesses out of the VAT system altogether.

VAT is the UK's third largest tax forecast to raise £161 billion in 2023/24, helping to fund key spending priorities such as important public services, including the NHS, education and defence. The previous VAT relief for tourism and hospitality cost over £8 billion and reintroducing it would come at a significant further cost.


Written Question
Vaccine Damage Payment Scheme: Coronavirus
Tuesday 13th February 2024

Asked by: Alexander Stafford (Conservative - Rother Valley)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 January 2024 to Question 9963 on Vaccine Damage Payment Scheme: Coronavirus, how many and what proportion of those 163 claimants have received an award in relation to a COVID-19 vaccination specifically.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

Of the 163 claims to the Vaccine Damage Payment Scheme that received an award between 31 December 2020 and 16 January 2024, 160 or 98% were claims related to COVID-19.